COVALIA study update: Interim Safety Results from needle-free SARS-CoV2 DNA vaccine phase 1 trial
Posted: 21 January 2022 – First needle-free SARS-CoV2 DNA vaccine tested in Australia is well tolerated – No safety concerns were observed – Ongoing study enrolment for booster dose Melbourne 17 January 2022 –Technovalia, an Australian biotech vaccine…
Illumina Genomics Summit – 1 February 2022
Pandemic permitting, Illumina will be holding an in-person event in Melbourne on the 1st February 2022 to engage the local community of genomics thought leaders for a day of collaboration and conversation around genomics as a key driver…
Record Support for Breakthrough mRNA Research
Posted: 4 January 2022 Closing: 19 January 2022 Victoria is leading the nation in mRNA research to fast-track sovereign manufacturing and health-care breakthroughs, today announcing the largest ever dedicated mRNA research grant program seen in Australia. Minister for…
Applications open for medical device development funding
Posted: 4 January 2022 In a move set to advance Australia’s medical technology sector, MTPConnect has announced that it is welcoming applications for its new Clinical Translation and Commercialisation – Medtech (CTCM) program. Supported by the Medical Research…
Sophie Stocker receives grant to lead charge for precision medicine research
Posted: 20 December 2021 Dr. Sophie Stocker, a senior lecturer at the University of Sydney, has been awarded a Ramaciotti Health Investment Grant of close to $100,000 by the Clive and Vera Ramaciotti Foundations to undertake medical research for precision medicine using a…
Industry Program – 2022 Health & Biomedical Researcher Development Program
EOIs closing 4 March 2022 The natural progression in the career of a successful researcher is to become head of your own research lab or group and stop spending time at the bench. You are no longer a…
MedTech Innovator Asia Pacific 2022 Accelerator Program – Applications now open
Posted: 13 December 2021 About MedTech Innovator Asia Pacific MedTech Innovator is the medical technology industry’s global showcase and accelerator for innovative medical device, digital health and diagnostic companies. The mission is to improve the lives of patients…
2022 ANDHealth+ cohort announced
Posted: 13 December 2021 BioMelbourne Network Member, ANDHealth, have welcomed the five companies selected for the 2022 ANDHealth+ program, Australia’s leading commercialisation program for digital health. The successful companies were announced by Dr Katie Allen, MP, Member for…
Inhaled AD-214 passes first development milestone
Posted: 13 December 2021 BioMelbourne Network Member, AdAlta Limited, the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, is pleased to announce that initial testing of AD-214 in nebulisation devices has exceeded expectations.…
BioMelbourne Network acknowledges The Honourable Greg Hunt MP
Posted 8 December BioMelbourne Network acknowledges and expresses its gratitude to the Minister for Health and Aged Care, The Honourable Greg Hunt MP, who has announced his retirement from politics prior to the next Federal election. Greg was…
$5M Boost to Innovation in Australia with New Illumina Genomics Lab
Posted 2 December New laboratory opens in Melbourne Biomedical Precinct to accelerate the adoption of genomics in healthcare and agriculture in Australia. Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new,…
Universal Biosensors Update
Posted: 1 December 2021 Below is an update from BioMelbourne Network Member Universal Biosensors. Sentia Universal Biosensors’ (UBI) development of our new Glucose, Fructose and Malic Acid biosensors for the wine industry is approaching completion with product release…
